Helsinn Group is a privately-owned pharmaceutical group with an extensive portfolio of marketed cancer care products, and its CEO Riccardo Braglia has over 35 years experience in the pharmaceutical industry.
On Thursday, May 7, at 11:00am CEST live on our YouTube channel, Netcomm Suisse president Carlo Terreni is interviewing Mr. Braglia to discover what the future of helthcare has in store thanks to newest digital technologies to tackle crisis like the Covid19 one and the role of Ticino in the coming years.
During the live interview, Mr. Braglia will answer directly to attendees questions submitted in the live chat. To access the interview and connect with Mr. Braglia, register for free using the quick form on the event page.
Riccardo Braglia, Helsinn Group’s Vice Chairman and CEO, Managing Director and Member of Helsinn Holding’s Board of Directors, Switzerland and Executive Committee for Helsinn Group’s strategic management, has a wealth of over 35 years of international experience in the pharmaceutical industry. Mr. Braglia heads the family-run, privately-owned pharmaceutical company, the Helsinn Group, founded in 1976, with a worldwide presence and focus on cancer therapeutics and supportive care, which is strongly committed to improving the everyday lives of people with cancer.
Mr. Braglia is Board Member of Helsinn Healthcare, Switzerland, Helsinn Advanced Synthesis, Switzerland, Helsinn Birex Pharmaceuticals, Ireland, Helsinn Pharmaceuticals (Beijing), China. He is Chairman of Helsinn Therapeutics, USA, as well as Président Directeur Général – Gérant Associé of Helsinn International Services, Monaco, Principality of Monaco and Chairman of Helsinn Investment Fund, Luxembourg.
The first and only
Swiss Association of
Centro Galleria 1 A
6928 Manno CH
@ Dagorà Innovation Hub
T. +41 (0) 91 210 47 36
VAT no.: CHE-485.124.256 IVA
T. +41 44 500 21 73
Blue Box, Chemin du Pré-Fleuri 3
1228 Plan-les-Ouates CH
T. +41 (0) 22 510 71 03
@ Fongit Foundation